Wetzlar, Germany / Hørsholm, Denmark. Leica Microsystems, world-leading providers of Total Digital Pathology solutions, and Visiopharm the leading provider of Histoinformatics Solutions for Life-Sciences, today announce the completed integration of Leica’s SlidePath Digital Image Hub with Visiopharm’s Whole-Slide InformaticsTM solutions for Digital Pathology. Users can now take advantage of superior image capture and management from […]
GERMANTOWN, Maryland and HILDEN, Germany- QIAGEN today announced it has entered into a partnership with Pfizer Inc. (NYSE: PFE) for the development of a companion molecular diagnostic test for use with an investigational Pfizer compound in global clinical development for treatment of non-small cell lung cancer (NSCLC). Financial terms of the agreement were not disclosed. […]
FAIRFIELD, Ohio — DNA Diagnostics Center (DDC) the largest provider of private DNA paternity and other DNA tests in the United States and around the world, announced today the company’s exclusive license in the US for the first non-invasive prenatal paternity test using SNP (single-nucleotide polymorphism) Microarray Technology, which requires only a simple blood draw […]
ZUG, Switzerland and ZURICH — SmartGene, a provider of innovative software services for the management and analysis of genetic data, and the Institute of Medical Microbiology (“IMM”), University of Zurich, Switzerland, today announced an expanded collaboration, under which the University of Zurich will make use of the SmartGene platform and its associated reference databases to […]
ROCKVILLE, Maryland and SEOUL, Korea — Seegene today announced the publication of an independent retrospective study evaluating the Seeplex® Diarrhea-V ACE (Seeplex® DV) assay. The study was published online on July 20 ahead of printingby the Journal of Clinical Microbiology (https://www.ncbi.nlm.nih.gov/pubmed/21775550). The assay was found to be sensitive, specific, convenient and reliable for the direct […]
SAN DIEGO and KONSTANZ, Germany — Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced it has partnered with LifeCodexx AG, a company focused on the development of clinically validated Next Generation Molecular Diagnostics, for the commercialization of prenatal laboratory testing services in Europe. The companies have agreed to collaborate in […]
RUNCORN, England – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it will be exhibiting at the 23rd European Congress of Pathology (ECP 2011) at the Helsinki Exhibition and Convention Centre, Helsinki, Finland, 27 August – 1 September. It will showcase its latest innovations for anatomical pathology applications under the […]
Lexington, MA – T2 Biosystems® announced today that it has closed a $23 million series D financing. The round was led by new investor Aisling Capital, LLC, which was joined by existing investors Flagship Ventures, Polaris Venture Partners, Flybridge Capital Partners, Physic Ventures, Partners Healthcare, Arcus Ventures, RA Capital, Camros Capital and WS Investments. In […]
SAN DIEGO — TrovaGene, Inc. (Pink Sheets: TROV.PK), a developer of transrenal molecular diagnostics, confirmed today that it regained ownership of its worldwide rights and control over its patent estate for transrenal technology for non-invasive prenatal applications and cancer through the termination of a license agreement between TrovaGene and Sequenom, Inc. (NASDAQ: SQNM). In 2008, […]
SUNNYVALE, Calif. — Cepheid (CPHD) today announced the release of an updated Xpert® BCR-ABL Monitor test, now reporting results to the International Scale. The test is being released as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. The test, which runs on Cepheid’s GeneXpert® System, detects the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
